Cummings Keith Lamont 4
4 · PLIANT THERAPEUTICS, INC. · Filed May 6, 2024
Insider Transaction Report
Form 4
Cummings Keith Lamont
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-05-02−21,000→ 76,047 totalExercise: $2.08Exp: 2029-01-24→ Common Stock (21,000 underlying) - Exercise/Conversion
Common Stock
2024-05-02$2.08/sh+21,000$43,680→ 271,713 total
Footnotes (2)
- [F1]Includes 858 shares of Common Stock acquired by the Reporting Person pursuant to an Employee Stock Purchase Plan program.
- [F2]25% of the shares subject to such option vested on December 31, 2019 and 1/48th of the shares subject to the option vested in substantially equal monthly installments thereafter, all of which were subject to the Reporting Person's continuous service to the Issuer on each such date.